CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review The Year in Cardiovascular Medicine 2020: Coronary Intervention Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO Registry Percutaneous Coronary Intervention Readmissions Where Are the Solutions?

Guideline2016 Jan 14;37(3):267-315.

JOURNAL:Eur Heart J. Article Link

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Roffi M, Patrono C, ESC Scientific Document Group. Keywords: Acute cardiac care; Acute coronary syndromes; Angioplasty; Anticoagulation; Apixaban; Aspirin; Atherothrombosis; Beta-blockers; Bivalirudin; Bypass surgery; Cangrelor; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Statin; Stent; Ticagrelor; Unstable angina; Vorapaxar

FULL TEXT PDF